Zai Lab Limited
ZLAB
$24.92
$0.110.44%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
9/26/2023
-
PR Newswire
9/21/2023
-
Tickeron - Stocks
9/19/2023
-
Ticker Report
9/18/2023
-
The Fly
9/18/2023
-
Globe Newswire
9/16/2023
-
Tickeron - Stocks
9/12/2023
-
Ticker Report
9/9/2023
-
Tickeron - Stocks
9/8/2023
-
Ticker Report
9/7/2023
-
Ticker Report
9/7/2023
-
SeekingAlpha
9/7/2023
-
Tickeron - Stocks
9/6/2023
-
Tickeron - Technical Analysis
9/6/2023
-
Tickeron - Technical Analysis
9/5/2023
-
TheStreet.com
9/5/2023
-
Ticker Report
9/5/2023
-
Fool.com Headlines
9/5/2023
-
Zolmax
9/2/2023
-
Tickeron - Stocks
9/1/2023
-
Zacks Investment Research
9/1/2023
-
Tickeron - Stocks
9/1/2023
-
Tickeron - Stocks
8/31/2023
-
Zacks Investment Research
8/31/2023
-
Tickeron - Stocks
8/31/2023
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 7, 2023
Period Date
Friday, June 30, 2023
Next Filing
Week of Nov 6 and 10 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
86 21 6163 2588
Address
Jinchuang Plaza
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Country
Year Founded
Business Description
Sector
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Its commercial...
more
